Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update

Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

(2013) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effectiveness of Teriparatide in Postmenopausal Women with Osteoporosis and Glucocorticoid Use: 3-Year Results from the EFOS Study

(2012) D. KARRAS et al.   JOURNAL OF RHEUMATOLOGY

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

(2012) S. Lekamwasam et al.   OSTEOPOROSIS INTERNATIONAL

Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial

(2012) M Hakala et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Clinical Question: What is the best approach to managing glucocorticoid-induced osteoporosis?

(2011) Juliet Compston   CLINICAL ENDOCRINOLOGY

Management and Treatment of Osteoporosis in Patients Receiving Long-term Glucocorticoid Treatment: Current Status of Adherence to Clinical Guidelines and Related Factors

(2011) Daijun Kirigaya et al.   INTERNAL MEDICINE

Nationwide Survey for Bisphosphonate-Related Osteonecrosis of the Jaws in Japan

(2011) Masahiro Urade et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Glucocorticoid-Induced Bone Disease

(2011) Robert S. Weinstein   NEW ENGLAND JOURNAL OF MEDICINE

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

(2011) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons

(2010) Toshiyuki Yoneda et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

(2009) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double-Blind, Placebo-Controlled Trial*

(2009) Astrid Fahrleitner-Pammer et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis

(2009) J.-P. DEVOGELAER et al.   JOURNAL OF RHEUMATOLOGY

Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial

(2009) S. A. STOCH et al.   JOURNAL OF RHEUMATOLOGY

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

(2009) B. L. Langdahl et al.   OSTEOPOROSIS INTERNATIONAL

Pregnancy outcome following in utero exposure to bisphosphonates

(2008) Shirley Levy et al.   BONE